April 11, 2025 03:32 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
PM Modi inaugurates Rs. 3,880-cr projects in Varanasi on 50th visit to his Lok Sabha constituency | Bengal job losers camp outside SSC office in Kolkata, demand mirror copies of genuine candidate list | Mumbai terror attack accused Tahawwur Rana sent to 18-day NIA custody | Donald Trump's latest tariff hike on Beijing brings additional rate on some Chinese goods to 145 pct: White House | Pakistan distances itself from 26/11 terror accused Tahawwur Rana, says he is 'Canadian national' | Tahawwur Rana’s extradition proof of Modi govt's diplomatic strength: Amit Shah | Adult unmarried parents can live together without marriage: Allahabad High Court | Bengal job losers hold massive rally in Kolkata protesting over police assault | Waqf Act won't be implemented in Bengal: Mamata Banerjee | Centre appoints advocate Narender Mann as special public prosecutor in Tahawwur Rana case
COVID-19: Dr. Reddy’s Laboratories announces commercial launch of 2DG

COVID-19: Dr. Reddy’s Laboratories announces commercial launch of 2DG

Jun 28, 2021, at 10:09 pm

Hyderabad: Dr. Reddy’s Laboratories Ltd. on Monday announced the commercial launch of 2-deoxy-D-glucose (2-DG).

DCGI approves DRDO's anti-COVID oral drug '2-DG' for emergency use

DCGI approves DRDO's anti-COVID oral drug '2-DG' for emergency use

May 08, 2021, at 11:57 pm

New Delhi/IBNS: The Drug Controller General of India (DCGI) has approved the emergency use of DRDO's anti-COVID-19 therapeutic oral drug 2-deoxy-D-glucose (2-DG) as an adjunct therapy in moderation to severe COVID-19 patients.

Close menu